Trialbee Partners with Clinerion to Accelerate Patient Recruitment for Clinical Trials

▴ Trialbee Partners with Clinerion to Accelerate Patient Recruitment for Clinical Trials
Expanded access to global real-world data to accelerate patient recruitment for Clinical Trials

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, announced a partnership with Clinerion, a worldwide leader in medical data informatics with a global research network comprised of 30.2 million patients online across 69 healthcare organizations in 15 countries. This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.

“This partnership significantly broadens our global reach and allows us to expand our data set for predictable intelligence-based patient recruitment and retention to support traditional and decentralized trials,” said Lollo Eriksson, CEO of Trialbee. “This is a great opportunity for both organizations to make trials simpler for investigators and to deliver on our commitment of expediting clinical research by optimizing the use of real-world data.”

More than eighty percent of trials are delayed and approximately thirty percent of sites never enroll patients because of limited access to patients who match the study criteria. The combination of Clinerion’s expertise in leveraging real-time, real-patient, and real-world electronic health record (EHR) data for clinical research combined with Trialbee’s unique multiple step qualification process, which includes online qualification and nurse practitioner interviews to ensure high-quality patient matches prior to obtaining consent and enrollment, will significantly improve and streamline this process. The Trialbee platform provides full transparency of the status of the referred patient flow throughout the entire clinical trial and continuously offers sites and sponsors full insight into the effectiveness of recruitment strategies.

“Patients are at the center of everything Clinerion does, and this partnership will ensure better outcomes for patients,” says Ian Rentsch, CEO of Clinerion. “Together, we will be able to match more of the right patients to the leading-edge trials that can bring them the care they need. And, ultimately, our improvement of the efficiency of recruitment for clinical trials will accelerate the introduction of new medicines and interventions.”

About Trialbee

Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option. Founded in 2010, Trialbee has continuously innovated patient-centric technology solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data.

Tags : #Trialbee #Clinerion #AccesstoRealWorldGlobalData #LatestCovidNewsUpdateAug28 #LatestPharmaNewsUpdateAug28 #LatestPharmaMergerNewsAug28

About the Author


Team Medicircle

Related Stories

01 Feb

Novavax applies for FDA emergency use authorization of its coronavirus vaccine

Latest Corporate News; Pharma Jan1st/2022

View
30 Dec

Novavax and SK bioscience Expand Manufacturing Agreement

Latest pharma news update

View
06 Jul

Spero Therapeutics entered into licensing agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories

Latest Pharma News Update

View
26 Jun

Country soon to get world’s first DNA-plasmid vaccine by Zydus Cadilla: Chairman COVID-19 NTAGI

Zydus Cadila vaccine to be available by September

View
24 Feb

Pfizer and Moderns pledges US Govt for 240 million doses of vaccine by March end

J&J also applied for emergency application

View
09 Feb

Afghanistan receives 500,000 doses of AstraZeneca’s COVID-19 vaccine from India

Afghanistan has had 55,335 COVID-19 cases and 2,410 deaths from the disease, according to the health ministry.

View
08 Feb

Today Bangladesh starts nationwide COVID-19 vaccination program

Bangladesh rolls out nationwide vaccination program with AstraZeneca-Oxford vaccine

View
15 Jan

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV

View
29 Dec

Novavax coronavirus vaccine becomes fifth to begin Phase 3 trials in United States

Novavax is also currently conducting a Phase 3 clinical study in the United Kingdom, a Phase 2b trial in South Africa and a Phase 1/2 continuation in the US and Australia

View
30 Nov

Novavax delays U.S. COVID-19 vaccine trial again, now sees start in the coming weeks

Vaccine maker Novavax Inc said on Monday it has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025